Second IVIg course in Guillain-Barre syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial

Autor: Walgaard, Christa, Jacobs, Bart C., Lingsma, Hester F., Steyerberg, Ewout W., Cornblath, David R., van Doorn, Pieter A., de Wit, M. C. Y., van den Berg, B., Doets, A. Y., Leonhard, S. E., Verboon, J. C., van Woerkom, M., Tio-Gillen, A. P., van Rijs, W., Huizinga, H., Badrising, U. A., Bienfait, H. M. E., Blom, R. J., van Boheemen, C. J. M., Breukelman, A. J., Bronner, I. M., Dieks, H. J. G., van Dijk, G. W., van Engelen, B. G. M., Faber, C. G., Feenstra, B., Fokke, C., Garssen, M. P. J., Gijsbers, C. J., Gilhuis, H. J., van der Graaff, M. M., Groen, R. J., Hoogendoorn, T. A., Hovestad, A., Jansen, P. J. H. W., Jellema, K., Keuter, E., Kleyweg, R. P., van Koningsveld, R., van der Kooi, A. J., van der Kooi, E. L., Krudde, J., Kuks, J. B. M., Kuitwaard, K., Linssen, W. H. J. P., Lion, J., Lovenich, H., Manschot, S. M., Mellema, S. J., Merkies, I. S. J., van der Meulen, M. F. G., van der Meulen, W. D. M., Molenaar, D. S. M., Oenema, D. G., van Oosten, B. W., van Oostrom, J. C. H., van Orshoven, N. P., van der Ploeg, R. J. O., van der Pol, W. L., Polman, S., van der Ree, T. C., de Rijk, M. C., Ruitenberg, A., Ruts, L., Samijn, J. P. A., Schyns-Soeterboek, A. J. G. M., Stevens, M., Vermeij, F. H., Verschuuren, J. J. G. M., Visser, L. H., Wirtz, P. W., Wohlgemuth, M., Zwetsloot, C. P., Dippel, D. W. J., Hintzen, R. Q.

Publikováno v: Journal of the Peripheral Nervous System
Journal of the Peripheral Nervous System, 23(4), 210-215. Wiley-Blackwell
Journal of the Peripheral Nervous System, 23, 4, pp. 210-215
Journal of the peripheral nervous system, 23(4), 210-215. Wiley-Blackwell
Journal of the Peripheral Nervous System, 23(4), 210-215
Journal of the Peripheral Nervous System, 23(4), 210-215. Wiley-Blackwell Publishing Ltd
Journal of the Peripheral Nervous System, 23, 210-215
the Dutch GBS Study Group 2018, ' Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial ', Journal of the Peripheral Nervous System, vol. 23, no. 4, pp. 210-215 . https://doi.org/10.1111/jns.12286

One course of intravenous immunoglobulins (IVIg) of 2 g/kg is standard treatment in Guillain-Barré syndrome (GBS) patients unable to walk independently. Despite treatment some patients recover poorly, in part related to rapid consumption of IVIg, in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df239f086b25e3d2d61e736367a97b4
https://doi.org/10.1111/jns.12286

On the influence of performance agreement on educational quality : a case study of the performance agreements of Tilburg University

Autor: Mellema, S.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=phd_tilb__nl::e1d6c96c6e3b9d7eceff555d30b6f196
http://tilburguniversity.worldcat.org/search?q=scr.uvt.nl:5907790

Spinal cord involvement in Balo's concentric sclerosis

Autor: Kreft, Karim L., Mellema, S. Jouke, Hintzen, Rogier Q.

Publikováno v: In Journal of the Neurological Sciences 2009 279(1):114-117

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.